Cardinal Buying Boron LePore, Highlights Pre-Launch Market Development

Cardinal Health is highlighting Boron LePore's pre-launch market development activities and relationships with smaller pharma/biotech firms as key assets in the proposed $194 mil. acquisition of the marketing services company